Status:

COMPLETED

Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics

Lead Sponsor:

Peking University Cancer Hospital & Institute

Conditions:

Esophagus Cancer

Eligibility:

All Genders

Brief Summary

This study proposes to establish a CT radiomics-based prediction model for identifying metastasis lymph nodes in esophageal cancer.

Detailed Description

This study proposes to establish an image feature extraction and selection method for identifying lymph node metastasis of esophageal cancer.The study will consider the relationship between the main l...

Eligibility Criteria

Inclusion

  • pathologically proven esophageal cancer
  • scheduled to preoperative enhanced chest CT and undergo surgery
  • sign the patient informed consent

Exclusion

  • failed to receive preoperative enhanced chest CT or undergo surgery
  • inavailable pathological results for local lymph node status
  • inquality of CT images for feature extraction
  • patient quit

Key Trial Info

Start Date :

February 15 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 15 2020

Estimated Enrollment :

133 Patients enrolled

Trial Details

Trial ID

NCT03237130

Start Date

February 15 2017

End Date

May 15 2020

Last Update

February 2 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Cancer Hospital

Beijing, Beijing Municipality, China, 100142